Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2008
11/18/2008US7452877 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452556 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride
11/18/2008US7452543 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences
11/18/2008CA2587127C Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
11/18/2008CA2519252C Biaryl substituted triazoles as sodium channel blockers
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2440222C Triazolopyridines as anti-inflammatory agents
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2397537C External plaster containing 4-biphenylyl acetic acid
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/18/2008CA2375743C Methods and compositions for the support, regeneration and repair of connective tissues
11/18/2008CA2362281C Combinations for the treatment of diseases involving angiogenesis
11/18/2008CA2359640C Topical sprays
11/18/2008CA2352275C Il-5 inhibiting 6-azauracil derivatives
11/18/2008CA2344057C Treatment of persistent pain
11/18/2008CA2339190C Compressed compositions comprising clarified xanthan gum
11/18/2008CA2316298C Fat blend
11/18/2008CA2314326C Transdermal therapeutic device and method with capsaicin and capsaicin analogs
11/18/2008CA2296492C Use of compositions containing the combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
11/18/2008CA2247115C Inhibition of selectin binding
11/18/2008CA2205112C Method and composition for treating mammalian diseases caused by inflammatory response
11/18/2008CA2172376C Antibodies to cd40
11/13/2008WO2008137915A2 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/13/2008WO2008137444A1 N-halogenated amino acid formulations with anti-inflammatory compounds
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008136754A1 Novel benzyl - 2 -oxo-piperazinyl/ 7-oxo/5-oxa- [1,4] diazepanyl/ 2 -oxo- tetrahydropyrimidinyl derivatives
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008136012A1 Oral medicinal preparations
11/13/2008WO2008135826A2 2 -pyridine carboxamide derivatives as sodium channel modulators
11/13/2008WO2008135767A1 New triazole compounds useful in the treatment of inflammation
11/13/2008WO2008135578A1 Pyrazolo [3, 4-d] pyrimidine derivatives for the treatment of inflammation and/or allergic conditions
11/13/2008WO2008135557A1 Organic compounds
11/13/2008WO2008135232A1 Use and compositions of purine derivatives for the treatment of proliferative disorders
11/13/2008WO2008135153A1 Novel polymorphic form of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008135152A1 Novel amorphous forms of 2-(4-fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methyl-sulfonyl)phenyl]-3(2h)-pyridazinone (fhmp)
11/13/2008WO2008134814A1 A method for treating inflammation and controlled-release material capable of providing same
11/13/2008WO2008109493A3 Nucleic acid compounds for inhibiting cd19 gene expression and uses thereof
11/13/2008WO2008109365B1 Nucleic acid compounds for inhibiting raf1 gene expression and uses thereof
11/13/2008WO2008100620A3 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
11/13/2008WO2008099072A3 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
11/13/2008WO2008081331A3 Enhancing the level of antibody expression by framework re-engineering
11/13/2008WO2008052072A3 Compounds for the treatment of pain and screening methods therefor
11/13/2008WO2008042611A3 Method of using il6 antagonists with mitoxantrone for prostate cancer
11/13/2008US20080281236 Devices and methodologies useful in body aesthetics
11/13/2008US20080280996 Rheumatic diseases; antiarthritic agents; osteoarthritis; lupus; inflammatory bowel disorders; psoriasis; atherosclerosis; cyclooxygenase inhibitor; antidepressants; blocks production of cytokines, tumor necrosis factor, prostaglandins
11/13/2008US20080280974 Spiro compounds for treatment of inflammatory disorders
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280965 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280952 Pyridine Derivatives as Connabinoid Receptor Modulators
11/13/2008US20080280949 Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
11/13/2008US20080280926 Phosphodiesterase Inhibitors
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280913 dipeptidyl-peptidase IV (DPP-IV) inhibitors such as 5,5,6,6,8,8-d6-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine; increasing hormone glucagon-like peptide levels; pharmacokinetics; side effect reduction
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280868 Pyridine Derivatives and Their Use as Cb2 Receptor Modulators
11/13/2008US20080280866 Administering to animal for risk of inflammatory damage to organs from trauma or sepsis a calcium channel moderator and kinase inhibitor
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280862 Methods, compositions, and kits for the treatment of pain
11/13/2008US20080280857 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
11/13/2008US20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods
11/13/2008US20080280812 Purified supernatant from Ntera2/D1-derived neurons; polyacrylamide gel electrophoresis produces 20 isoelectric fractions, including active isoelectric fraction #10; Blue Sepharose column to bind albumin; collect free fraction
11/13/2008US20080280327 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases
11/13/2008US20080280308 G protein coupled receptor signaling modulation
11/13/2008US20080279948 Treatment of Asthma and Copd Using Triple-Combination Therapy
11/13/2008US20080279938 Zaltoprofen-containing sustained release tablet and process for the preparation thereof
11/13/2008US20080279862 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders
11/13/2008US20080279857 Therapeutic Agent
11/13/2008US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279851 Type I transmembrane protein specific immunoglobulin for treatment and prevention of cell proliferative and inflammatory disorders
11/13/2008US20080279849 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis
11/13/2008US20080279841 Novel Therapeutic Molecular Variants And Uses Thereof
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can
11/13/2008DE102007021862A1 Wässrige pharmazeutische Zubereitung Aqueous pharmaceutical preparation
11/13/2008CA2685956A1 A method for treating inflammation and controlled-release material capable of providing same
11/13/2008CA2685546A1 Organic compounds
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684186A1 N-halogenated amino acid formulations with anti-inflammatory compounds
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990051A1 Combinations of SSRI and estrogenic agents
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1989208A1 New morphine compounds for pharmaceutical compositions
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1989187A1 2-(phenyl or heterocyclic) - 1h-phenanthro (9,10-d) imidazoles
11/12/2008EP1988886A1 Delayed release pharmaceutical oral dosage form and method of making same
11/12/2008EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
11/12/2008EP1549648B1 Bicyclic heteroaromatic compounds as kinase inhibitors
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008EP1261607B1 2,4-disubstituted thiazolyl derivatives
11/12/2008CN101305021A Compositions and methods for diagnosing and treating an inflammation
11/12/2008CN101305000A 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 1272